Skip to main content
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.
Cholesterol: An Achilles' Heel for Glioblastoma?
An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
PPAR?: Welcoming the New Kid on the CML Stem Cell Block.
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Drugging MYCN through an allosteric transition in Aurora kinase A.
When deletions gain functions: commandeering epigenetic mechanisms.
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.